{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:48:12Z","timestamp":1772146092871,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ymgme.2009.07.013","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T13:23:12Z","timestamp":1248873792000},"page":"383-392","source":"Crossref","is-referenced-by-count":53,"title":["Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs\u2014A proof of principle study"],"prefix":"10.1016","volume":"98","author":[{"given":"Kim M.","family":"Hemsley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison C.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyane","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie L.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2009.07.013_bib1","first-page":"381","article-title":"The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment","volume":"7","author":"Hopwood","year":"1990","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/j.ymgme.2009.07.013_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng1295-465","article-title":"Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome","volume":"11","author":"Scott","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2009.07.013_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/dnares\/3.4.269","article-title":"Structure and sequence of the human sulphamidase gene","volume":"3","author":"Karageorgos","year":"1996","journal-title":"DNA Res."},{"key":"10.1016\/j.ymgme.2009.07.013_bib4","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.07.013_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"Suppl.","key":"10.1016\/j.ymgme.2009.07.013_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2009.07.013_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2009.07.013_bib8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2009.07.013_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2009.07.013_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.07.013_bib11","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.07.013_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2009.07.013_bib13","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2009.07.013_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2009.07.013_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","article-title":"Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2009.07.013_bib16","first-page":"359","article-title":"Stem cell bone marrow transplantation in patients with metabolic storage diseases","volume":"49","author":"Krivit","year":"2002","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2009.07.013_bib17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European group for bone marrow transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2009.07.013_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1005526628598","article-title":"Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling","volume":"22","author":"Sivakumur","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2009.07.013_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1601-183X.2008.00413.x","article-title":"Effect of high dose, repeated intra-CSF injection of sulphamidase on neuropathology in MPS IIIA mice","volume":"7","author":"Hemsley","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ymgme.2009.07.013_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1460-9568.2009.06666.x","article-title":"Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease","volume":"29","author":"Hemsley","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymgme.2009.07.013_bib24","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ymgme.2009.07.013_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/00480169.2000.36181","article-title":"Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia","volume":"48","author":"Jolly","year":"2000","journal-title":"NZ Vet. J."},{"key":"10.1016\/j.ymgme.2009.07.013_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/geno.2002.6699","article-title":"Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs","volume":"79","author":"Yogalingam","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2009.07.013_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1354\/vp.44-5-569","article-title":"Pathology of mucopolysaccharidosis IIIA in Huntaway dogs","volume":"44","author":"Jolly","year":"2007","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2009.07.013_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2006.02.013","article-title":"Newborn screening for lysosomal storage disorders","volume":"88","author":"Meikle","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0009-8981(82)90168-1","article-title":"Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate","volume":"123","author":"Hopwood","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2009.07.013_bib30","first-page":"733","volume":"56","author":"Fuller","year":"2004","journal-title":"Disease-specific markers for the mucopolysaccharidoses, Pediatrics"},{"key":"10.1016\/j.ymgme.2009.07.013_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2005.09.026","article-title":"Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA","volume":"87","author":"King","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","article-title":"Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications","volume":"18","author":"Yogalingam","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2009.07.013_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/mgme.2001.3190","article-title":"Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients","volume":"73","author":"Perkins","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.07.013_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.05.079","article-title":"Characterization of a C57BL\/6 congenic mouse strain of mucopolysaccharidosis type IIIA","volume":"1104","author":"Crawley","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2009.07.013_bib35","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1021\/ac052083d","article-title":"Characterization of sulfated oligosaccharides in mucopolysaccharidosis type IIIA by electrospray ionization mass spectrometry","volume":"78","author":"Mason","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2009.07.013_bib36","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.07.013_bib37","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2009.07.013_bib38","series-title":"Lysosomal Disorders of the Brain: Recent Advances in Molecular and Cellular Pathogenesis and Treatment","first-page":"327","article-title":"Enzyme replacement therapy","author":"Neufeld","year":"2004"},{"key":"10.1016\/j.ymgme.2009.07.013_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00109-008-0309-3","article-title":"Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease","volume":"86","author":"Matzner","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2009.07.013_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.07.013_bib41","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1096\/fj.06-6169com","article-title":"Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy","volume":"21","author":"Lee","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2009.07.013_bib42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11916-001-0068-0","article-title":"Spinal drug delivery","volume":"5","author":"Grabow","year":"2001","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.ymgme.2009.07.013_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1566523013348445","article-title":"Vector delivery methods and targeting strategies for gene therapy of brain tumors","volume":"1","author":"Rainov","year":"2001","journal-title":"Curr. Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T02:10:58Z","timestamp":1590027058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719209002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1096719209002376"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2009.07.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}